In this study, the authors demonstrated that these improvements were specifically mediated by the inhibition of renal artery angiotensin II receptor type I/endothelin-1 axis (19), suggesting that much of the damage in diabetic nephropathy in this model was mediated via vascular effects. The gene discussed is EDN1; the disease is diabetic kidney disease.